reading time

Oxford Nanopore Share Price

Oxford Nanopore Technologies has attracted significant funding from various sources, including venture capital firms, strategic partners, and government grants. In addition, the company’s innovative nanopore sequencing technology has garnered attention and interest from the scientific community and industry.

Oxford Nanopore Share Price

Oxford Nanopore Technologies was still a private company not listed on the London Stock Exchange (LSE). As of this post, the Oxford Nanopore Share Price is 261.20 GBX.

Oxford Nanopore Share Price

Brief History of Oxford Nanopore Share Price

Oxford Nanopore Share Price is a UK-based company specializing in developing nanopore sequencing technology. Here is a brief history of the company:

Oxford Nanopore Technologies was founded in 2005 by Hagan Bayley, Gordon Sanghera, and Spike Willcocks. The company emerged from research conducted at the University of Oxford.

In 2007, Oxford Nanopore Technologies raised significant funding and began developing its proprietary nanopore sequencing technology. The technology aims to enable the direct electrical identification and analysis of biological molecules, including DNA, RNA, and proteins.

2014 the company launched its first commercial product, the MinION, a portable nanopore sequencer. The MinION gained attention for its potential to provide real-time sequencing in various settings, including remote locations and during fieldwork.

Oxford Nanopore continued to innovate and expand its product line. In 2017, the company introduced the GridION system, a scalable benchtop sequencer, and in 2019, it launched the PromethION, a high-throughput nanopore sequencer designed for large-scale projects.

The company has collaborated with various academic institutions, research organizations, and industry partners to advance its technology and applications further. As a result, Oxford Nanopore’s technology has been used in various fields, including genomics, microbiology, agriculture, and infectious disease research.

In 2020, Oxford Nanopore announced plans for an initial public offering (IPO) on the London Stock Exchange. The IPO plans were reported to be delayed multiple times, with potential listings speculated for 2021 and 2022. However, please remember that my knowledge is based on information available until September 2021, and the IPO may have occurred since then.

Advantages of Investing in Oxford Nanopore Share Price

Some potential advantages that are often associated with investing in biotechnology companies like Oxford Nanopore Share Price:

Innovative Technology

Oxford Nanopore Technologies is known for its pioneering nanopore sequencing technology, which has the potential to revolutionize the field of DNA sequencing. Investing in companies with cutting-edge technology can offer significant growth opportunities if their technology proves successful and gains widespread adoption.

Market Potential

The genomics market and DNA sequencing industry have experienced substantial growth in recent years. Oxford Nanopore Share Price’s technology aims to provide faster, more accessible, and more cost-effective sequencing solutions, which could position the company to capture a significant market share.


Investing in a biotechnology company like Oxford Nanopore Share Price can diversify a portfolio. BiotechIn addition, biotechments can be less correlated with traditional market movements, offering a hedge against market volatility.

Partnerships and Collaborations

Oxford Nanopore Share Price has established collaborations with various academic institutions, research organizations, and industry partners. These partnerships can enhance the company’s capabilities, expand its reach, and open doors to new opportunities.

Potential for Future IPO

As mentioned earlier, there were reports of Oxford Nanopore Share Price considering an IPO on the London Stock Exchange. If the company goes public, it could allow investors to participate in its growth and generate returns.

Main Competitors of Oxford Nanopore Share Price

  1. Illumina: Illumina is a leading company in the DNA sequencing market, offering a range of sequencing platforms and related products. They have a strong presence in the research, clinical, and industrial markets.
  2. Pacific Biosciences (PacBio): PacBio develops and markets DNA sequencing systems based on its proprietary single-molecule real-time (SMRT) sequencing technology. They provide long-read sequencing capabilities, which can be advantageous for specific applications.
  3. Thermo Fisher Scientific: Thermo Fisher Scientific is a major player in the life sciences industry, offering a wide range of products and services, including DNA sequencing platforms, reagents, and bioinformatics solutions.
  4. BGI Genomics: BGI Genomics, the Beijing Genomics Institute, is a leading genomics research institution and service provider. They offer sequencing services and have developed their sequencing platforms, such as the BGISEQ sequencers.
  5. Roche Sequencing: Roche Sequencing, a division of Roche Diagnostics, develops and manufactures DNA sequencing systems, including the 454 Sequencing System. They have a presence in both research and clinical applications.

The Best Copytrading Platform

eToro UK
Minimum deposit 200 USD
Regulated in Europe
Trade selections Forex, Crypto, Stocks, Commodities, ETFs, Indices
  • Zero Commissions on Trades

  • CopyPortfolios/Copytrade Feature

  • Ask Experts Questions

  • Wide Range of Stocks


Oxford Nanopore has been recognized as a critical player in DNA sequencing, competing with established companies like Illumina and Pacific Biosciences. In addition, the company’s technology offers unique advantages, such as real-time sequencing and portability, contributing to its appeal and potential market impact.


FAQ: Oxford Nanopore Share Price

Does Oxford Nanopore Technologies PLC pay dividends to its stockholders?

Oxford Nanopore Technologies was a private company; therefore, it did not have publicly traded stock or stockholders. As a private company, it is not obligated to pay its investors or stockholders dividends.

Who are the target investors of Oxford Nanopore Technologies PLC?

Oxford Nanopore Technologies was a private company, and specific information about its target investors was not publicly available. However, private companies typically raise funds from various sources, including venture capital firms, private equity investors, strategic partners, and government grants.
However, given the nature of the biotechnology industry and the potential market impact of Oxford Nanopore's nanopore sequencing technology, the company may have attracted interest from diverse investors. This could include investors focusing on the life sciences, genomics, and biotechnology sectors and those looking for opportunities in disruptive technologies and innovations.

What is the moat of Oxford Nanopore Technologies PLC?

Nanopore Sequencing Technology: Oxford Nanopore's core technology is based on nanopores, tiny holes that allow individual molecules, such as DNA or RNA, to pass through. Oxford Nanopore can identify and sequence the molecules in real-time by measuring the electrical signals produced as the molecules pass through the nanopores. This technology offers several advantages, including the potential for portable, fast, and cost-effective sequencing with long read lengths.

Real-time Analysis: One of the critical advantages of Oxford Nanopore's technology is the ability to perform real-time analysis. Traditional sequencing methods often require time-consuming sample preparation and data processing before results are obtained. Oxford Nanopore's technology allows for immediate analysis as the ongoing sequencing process enables researchers to make decisions and interpretations in real time.

Portability and Accessibility: Oxford Nanopore's sequencing devices, such as the MinION and GridION, are designed to be portable and easy to use. These devices' small size and portability enable sequencing in various environments, including remote locations or the field. This accessibility makes Oxford Nanopore's technology attractive for applications requiring real-time sequencing outside of traditional laboratory settings.

Long Read Lengths: Oxford Nanopore's technology is known for generating long sequencing reads. Long-read sequencing provides advantages in areas such as de novo genome assembly, structural variant analysis, and the characterization of complex genomic regions. This capability sets Oxford Nanopore apart from competing sequencing technologies that may have limitations in read length.

Rate this post
Simon Williams
Latest posts by Simon Williams (see all)